News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,083 Results
Type
Article (5012)
Company Profile (17)
Press Release (220054)
Section
Business (82207)
Career Advice (461)
Deals (15044)
Drug Delivery (8)
Drug Development (19073)
Employer Resources (30)
FDA (3677)
Job Trends (3902)
News (120131)
Policy (7506)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (293)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14769)
ALS (19)
Alzheimer's disease (248)
Antibody-drug conjugate (ADC) (11)
Approvals (3694)
Artificial intelligence (40)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2864)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (438)
Cardiovascular disease (22)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16023)
Collaboration (164)
Compensation (163)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (99)
Cystic fibrosis (16)
Data (503)
Depression (5)
Diabetes (40)
Diagnostics (2040)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40776)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37720)
Executive appointments (303)
FDA (3924)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (180)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (107)
Government (412)
Guidances (16)
Healthcare (5040)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7822)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (53)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3863)
Medtech (3864)
Mergers & acquisitions (7425)
Metabolic disorders (118)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (339)
NextGen: Class of 2025 (1675)
Non-profit (727)
Northern California (905)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (26)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24567)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4775)
Phase II (6956)
Phase III (5548)
Pipeline (541)
Policy (8)
Postmarket research (625)
Preclinical (1870)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1875)
Recruiting (8)
Regulatory (5114)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (23)
Sickle cell disease (7)
Southern California (687)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (3)
United States (6905)
Vaccines (36)
Venture capitalists (2)
Weight loss (20)
Women's health (1)
Date
Today (2)
Last 7 days (122)
Last 30 days (713)
Last 365 days (10035)
2025 (2821)
2024 (11029)
2023 (13198)
2022 (18666)
2021 (19687)
2020 (18248)
2019 (13211)
2018 (10214)
2017 (10003)
2016 (9162)
2015 (12121)
2014 (9593)
2013 (7713)
2012 (8331)
2011 (8796)
2010 (8636)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11443)
Australia (1606)
California (1899)
Canada (688)
China (70)
Colorado (80)
Connecticut (91)
Delaware (29)
Europe (24498)
Florida (267)
Georgia (33)
Idaho (23)
Illinois (111)
India (6)
Indiana (62)
Iowa (1)
Japan (67)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (218)
Massachusetts (1527)
Michigan (85)
Minnesota (137)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (554)
New Mexico (5)
New York (466)
North Carolina (321)
North Dakota (2)
Northern California (905)
Ohio (55)
Oklahoma (5)
Oregon (3)
Pennsylvania (338)
Puerto Rico (1)
Rhode Island (12)
South America (276)
South Carolina (4)
Southern California (687)
Tennessee (38)
Texas (221)
Utah (59)
Virginia (43)
Washington D.C. (9)
Washington State (169)
West Virginia (2)
Wisconsin (21)
225,083 Results for "neurologica corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
NeuroLogica Corp Receives Innovative Technology Designation from Vizient for OmniTom Elite PCD
NeuroLogica Corp. announces its OmniTom Elite PCD has received an Innovative Technology designation from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the country.
January 11, 2024
·
3 min read
FDA
NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64
NeuroLogica Announces FDA 510(k) Clearance of BodyTom ® 64.
November 28, 2022
·
3 min read
Genetown
NeuroLogica Installs Next-Generation SmartMSU™ with OmniTom® Elite in the Asia-Pacific Region
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of its SmartMSU™ with OmniTom® Elite – a specialized ambulance that is equipped with a small computed tomography (CT) scanner for head imaging – in the Asia-Pacific region.
December 15, 2022
·
4 min read
Genetown
NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced a partnership with The University of Dundee in Scotland, United Kingdom, to collaborate on research using the OmniTom® Elite with Photon Counting Detector computed tomography imaging technology.
January 4, 2023
·
3 min read
Genetown
NeuroLogica Receives CE Marking for all Elite Mobile Computed Tomography Systems
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced today that its state-of-the-art Elite Mobile Computed Tomography (CT) systems have received the European Union (EU) CE marking via compliance with the new EU Medical Device Regulation (MDR 2017/745).
October 12, 2022
·
3 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Genetown
NeuroLogica Announces FDA 510(k) Clearance for Photon Counting Computed Tomography Using OmniTom Elite
The world of medical imaging is no longer just black & white. NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced today its state-of-the-art OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology.
March 10, 2022
·
3 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
Genetown
Samsung NeuroLogica Receives Authority to Operate from the Defense Health Agency for RS85 Prestige
Samsung NeuroLogica Corp. today announced that it received the Risk Management Framework approval, Authority to Operate (ATO) from the Defense Health Agency for its RS85 Prestige Ultrasound.
August 11, 2021
·
2 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
1 of 22,509
Next
